These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: the need for large-scale randomized trials. Bradley DJ; Shen WK Heart Rhythm; 2007 Feb; 4(2):224-32. PubMed ID: 17275763 [TBL] [Abstract][Full Text] [Related]
4. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Dong K; Shen WK; Powell BD; Dong YX; Rea RF; Friedman PA; Hodge DO; Wiste HJ; Webster T; Hayes DL; Cha YM Heart Rhythm; 2010 Sep; 7(9):1240-5. PubMed ID: 20156595 [TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes After Ablation of the AV Junction in Patients With Atrial Fibrillation: Impact of Cardiac Resynchronization Therapy. Mittal S; Musat DL; Hoskins MH; Prillinger JB; Roberts GJ; Nabutovsky Y; Merchant FM J Am Heart Assoc; 2017 Nov; 6(12):. PubMed ID: 29180458 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm. Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182 [TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. Brignole M; Pokushalov E; Pentimalli F; Palmisano P; Chieffo E; Occhetta E; Quartieri F; Calò L; Ungar A; Mont L; Eur Heart J; 2018 Dec; 39(45):3999-4008. PubMed ID: 30165479 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and cardiac resynchronization therapy. Gasparini M; Galimberti P Curr Opin Cardiol; 2018 Jan; 33(1):1-6. PubMed ID: 29045344 [TBL] [Abstract][Full Text] [Related]
11. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542 [TBL] [Abstract][Full Text] [Related]
12. Atrioventricular junction ablation in patients with atrial fibrillation treated with cardiac resynchronization therapy: positive impact on ventricular arrhythmias, implantable cardioverter-defibrillator therapies and hospitalizations. Gasparini M; Kloppe A; Lunati M; Anselme F; Landolina M; Martinez-Ferrer JB; Proclemer A; Morani G; Biffi M; Ricci R; Rordorf R; Mangoni L; Manotta L; Grammatico A; Leyva F; Boriani G Eur J Heart Fail; 2018 Oct; 20(10):1472-1481. PubMed ID: 29251799 [TBL] [Abstract][Full Text] [Related]
13. A pilot study to assess benefit of atrial rhythm control after cardiac resynchronization therapy and atrioventricular node ablation. Schwartzman D; Housel D; Bazaz R; Jain S; Saba S; Gorcsan J; Adelstein E Pacing Clin Electrophysiol; 2015 Feb; 38(2):275-81. PubMed ID: 25431023 [TBL] [Abstract][Full Text] [Related]
14. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation. Himmel F; Reppel M; Mortensen K; Schunkert H; Bode F Pacing Clin Electrophysiol; 2012 Aug; 35(8):943-7. PubMed ID: 22650352 [TBL] [Abstract][Full Text] [Related]
15. Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blind study. Palmisano P; Aspromonte V; Ammendola E; Dell'era G; Ziacchi M; Guerra F; Aquilani S; Maglia G; Del Giorno G; Giubertoni A; Boriani G; Capucci A; Pietro Ricci R; Accogli M; Europace; 2017 Mar; 19(3):414-420. PubMed ID: 26941340 [TBL] [Abstract][Full Text] [Related]
16. [Permanent atrial fibrillation and heart failure: radiofrequency ablation of atrioventricular junction and cardiac resynchronization therapy: review of the literature and of the new techniques for echocardiographic assessment]. Proclemer A; Allocca G; Badano LP; Pavoni D; Baldassi M; Nucifora G; Facchin D; Fioretti PM G Ital Cardiol (Rome); 2007 Apr; 8(4):215-24. PubMed ID: 17506293 [TBL] [Abstract][Full Text] [Related]
17. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438 [TBL] [Abstract][Full Text] [Related]
18. AV junction ablation in heart failure patients with atrial fibrillation treated with cardiac resynchronization therapy: the picture is now clear! Gasparini M; Galimberti P J Am Coll Cardiol; 2012 Feb; 59(8):727-9. PubMed ID: 22340264 [No Abstract] [Full Text] [Related]
19. Device Therapy for Rate Control: Pacing, Resynchronisation and AV Node Ablation. Lau DH; Thiyagarajah A; Willems S; Rostock T; Linz D; Stiles MK; Kaye D; Kalman JM; Sanders P Heart Lung Circ; 2017 Sep; 26(9):934-940. PubMed ID: 28687248 [TBL] [Abstract][Full Text] [Related]
20. Current role of atrioventricular junction (AVJ) ablation. Hoffmayer KS; Scheinman M Pacing Clin Electrophysiol; 2013 Feb; 36(2):257-65. PubMed ID: 23078186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]